StockData
Apyx Medical Corp logo

Apyx Medical Corp (APYX) income statement

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3018% above fair value
$2.56−0.09 (-3.58%)

Close on Nov 17, 2026Market cap $107.63MP/E –Yield –

Apyx Medical Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
63.5%
Operating margin
-6.1%
Net margin
-14.8%
Return on equity, FY2025
-78.0%

Financial strength

Current ratio
5.68
Debt to equity
3.31
Debt to assets
57.8%
Cash to current liabilities
295.2%

Valuation

P/E ratio
–
Price to sales
1.84
Price to book
10.09
Dividend yield
–

See a number that looks wrong?